Organization | General Mills Inc.

General Mills Inc. Report issue

For profit

Founded: Minneapolis MN United States (1856)

Status: No NME R&D (1856)

Organization Overview

First Clinical Trial

2007

NCT00618488

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2021

Timeline

NOW

Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

General Mills | General Mills Inc.

Active Ingredients

Drugs in Other Trials (15)

Key: General Mills Inc. (13) Acquired (2)

beta-glucans (1 trial)

bifidobacterium animalis (1 trial)

calcium (1 trial)

corn starch (1 trial)

glucose polymer fiber (1 trial)

inulin (1 trial)

isomalto-oligosaccharide (1 trial)

long-chain triglyceride (1 trial)

maltodextrin (1 trial)

medium chain triglyceride (1 trial)

prebiotic fiber (1 trial)

refined grain (2 trials)

sucromalt (1 trial)

vitamin d3 (1 trial)

zea mays starch (1 trial)

Indications

Overview

Highest Phase: Phase 0
# of Trials: 10
# of Trial APIs: 15